I've never been overly concerned about the share count because with the massive revenue potential of the products coming to market, it seems likely some of those revenues would be used for share buybacks to reduce the share expansion necessary during the pre-revenue stage of the company.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links